BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $351,000 | -35.9% | 6,518 | -23.6% | 0.40% | -45.1% |
| Q2 2022 | $548,000 | -3.9% | 8,532 | +16.1% | 0.73% | -4.3% |
| Q1 2022 | $570,000 | +352.4% | 7,347 | +401.8% | 0.76% | +435.0% |
| Q4 2021 | $126,000 | -73.4% | 1,464 | -75.1% | 0.14% | -72.8% |
| Q2 2021 | $473,000 | +107.5% | 5,877 | +107.2% | 0.53% | +75.9% |
| Q4 2020 | $228,000 | -73.4% | 2,836 | -73.4% | 0.30% | -77.3% |
| Q3 2020 | $856,000 | +220.6% | 10,647 | +259.9% | 1.32% | +273.9% |
| Q2 2020 | $267,000 | -53.9% | 2,958 | -57.3% | 0.35% | -37.8% |
| Q4 2019 | $579,000 | +99.0% | 6,923 | +108.3% | 0.57% | +95.8% |
| Q3 2019 | $291,000 | +665.8% | 3,324 | +625.8% | 0.29% | +622.5% |
| Q2 2019 | $38,000 | +1800.0% | 458 | +1808.3% | 0.04% | +1900.0% |
| Q1 2019 | $2,000 | -99.5% | 24 | -99.6% | 0.00% | -99.7% |
| Q4 2018 | $381,000 | -9.3% | 5,780 | +6.0% | 0.65% | +2.8% |
| Q3 2018 | $420,000 | -31.4% | 5,454 | -34.3% | 0.63% | -20.7% |
| Q2 2018 | $612,000 | +130.9% | 8,296 | +103.7% | 0.80% | +90.9% |
| Q1 2018 | $265,000 | -54.3% | 4,073 | -54.6% | 0.42% | -38.7% |
| Q4 2017 | $580,000 | +57900.0% | 8,967 | +44735.0% | 0.68% | +22633.3% |
| Q3 2014 | $1,000 | -99.7% | 20 | -99.5% | 0.00% | -99.6% |
| Q2 2014 | $297,000 | -1.0% | 4,109 | +0.9% | 0.76% | -13.7% |
| Q1 2014 | $300,000 | +9900.0% | 4,073 | +9597.6% | 0.89% | +29433.3% |
| Q4 2013 | $3,000 | -99.8% | 42 | -99.8% | 0.00% | -99.8% |
| Q2 2013 | $1,315,000 | – | 18,979 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |